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Abstract 
Elevation of intracranial pressure (ICP) may occur in many diseases and therefore the ability 
to measure it non-invasively would be useful. Flow velocity signals from Transcranial 
Doppler (TCD) have been used to estimate ICP, however the relative accuracy of these 
methods is unclear. This study aimed to compare 4 previously described TCD-based 
methods with directly measured ICP in a prospective cohort of head injured patients. Non-
invasive ICP (nICP) was obtained using the following methods: I) a mathematical “black-box” 
model based on interaction between TCD and ABP (nICP_BB); II) based on diastolic FV 
(nICP_FVd); III) based on critical closing pressure (nICP_CrCP) and IV) based on TCD-derived 
pulsatility index (nICP_PI).  
In time domain, for recordings including spontaneous changes in ICP greater than 7 mmHg, 
nICP_PI showed the best correlation with measured ICP (R=0.61). Considering every TCD 
recording as an independent event, nICP_BB generally showed to be the best estimator of 
measured ICP (R=0.39, p<0.05; 95% CI=9.94 mmHg; AUC= 0.66, p<0.05). For nICP_FVd, 
although it presented similar correlation coefficient to nICP_BB and marginally better AUC 
(0.70, p<0.05), it demonstrated a greater 95% CI for prediction of ICP (14.62 mmHg). 
nICP_CrCP presented a moderate correlation coefficient (R=0.35, p<0.05) and similar 95% CI 
to nICP_BB (9.19 mmHg), but failed to distinguish between normal and raised ICP 
(AUC=0.64, p>0.05). nICP_PI was not related to measured ICP using any of the above 
statistical indicators. We also introduced a new estimator (nICP_Av) based on the average of 
3 methods (nICP_BB, nICP_FVd and nICP_CrCP), which overall presented improved statistical 
indicators (R=0.47, p<0.05; 95% CI=9.17 mmHg; AUC= 0.73, p<0.05). 
nICP_PI appeared to reflect changes in ICP in time most accurately. nICP_BB was the best 
estimator for ICP ‘as a number’. nICP_Av demonstrated to improve the accuracy of 
measured ICP estimation.    
Keywords  
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Introduction 
 
Intracranial Pressure (ICP) has at least four components, driven by different physiological 
mechanisms1. The first component is associated with arterial blood inflow and volume of 
arterial blood. Most common phenomenon associated with this component is plateau wave 
of ICP. Second component of ICP is associated with venous blood outflow. Every obstruction 
to the outflow of blood leads to elevation of ICP (like venous compression due to wrong 
head position, but also venous thrombosis). Third component is related to problems with 
cerebrospinal fluid (CSF) circulation, like commonly seen in ‘acute hydrocephalus’ after brain 
injury or subarachnoid haemorrhage. In neurocritical care this component is commonly 
eradicated by extraventricular drainage. Finally, the fourth component is related to increase 
in brain volume (oedema) or volume of contusion (like haematoma). Osmotherapy or 
surgical decompression is commonly used to eradicate this component.  In clinical practice, 
it is important not only to monitor absolute value of ICP, but also to recognize which 
component is responsible for observed intracranial hypertension, as clearly different 
measures are appropriate for controlling different components. 
Direct intracranial pressure measurement requires invasive insertion of a pressure 
transducer within the cerebrospinal fluid compartment or the brain tissue. However, 
because of the risk of infection or bleeding, direct measurement of ICP is not often 
considered. To provide alternatives for patients who might benefit from ICP monitoring, 
some attempts have been made to develop methods to assess it non-invasively and 
continuously.  
Several methods for non-invasive assessment of ICP (nICP) have been described so far: 
Transcranial Doppler Ultrasonography (TCD) to measure cerebral blood flow velocity 
indices2; skull vibrations3;  brain tissue resonance4, or transcranial time of flight5; venous 
ophthalmodynamometry6; optic nerve sheath diameter assessment (ONSD)7; sensing 
tympanic membrane displacement (TMD)8,9; otoacoustic emissions10;  magnetic  resonance 
imaging to estimate intracranial compliance11; ultrasound guided eyeball compression12 and 
recordings of visual evoked potentials13. These methods are better suited for one-point 
assessment of instant value of ICP rather than continuous monitoring. Reported absolute 
accuracies (95% confidence interval for prediction of ICP) are described for transcranial time 
of flight as 20 mmHg and 9 mmHg; 3-5 mmHg for ophthalmodynamometry; 5-10 mmHg for 
ONSD, 15-20 mmHg for TMD and otoacoustic emissions14 and 9-16 mmHg for methods 
based on TCD waveforms.   
TCD waveform analysis, due to its sensitivity to detect changes in cerebral blood flow, has 
been investigated as a non-invasive ICP estimator15–29. In these methods, the insonated 
compliant middle cerebral artery (MCA) is interpreted as a ‘biological’ pressure transducer, 
whose walls can be deflected by transmural pressure (equivalent to cerebral perfusion 
pressure (CPP)), modulating accordingly the pulsatile waveform of cerebral blood flow 
velocity (FV). Transmission of this ‘transducer’, its linearity, stability in time and calibration 
coefficients are unknown - and these factors mainly contribute to limited accuracy of TCD-
based methods. The absolute error may be compensated for by the ability to monitor 
dynamics of changes in measured ICP and also because monitoring can easily be repeated 
bedside without any risk for the patient.  
Existing non-invasive ICP methods based on TCD waveform analysis present with different 
confidence intervals for prediction of ICP in traumatic brain injury (TBI) patients. Schmidt et 
al., applying a mathematical “black-box” model (i.e., based not on physiological structure, 
but rather on a set of formal mathematical expressions) to estimate ICP from cerebral blood 
flow velocity (FV) and arterial blood pressure (ABP), found a maximum 95% confidence 
interval (CI) for ICP prediction of 12.8 mmHg15; Heldt et al., also using a model based on FV 
and ABP found 15 mmHg27 ; and Bellner et al., investigating the relationship between ICP 
and TCD-derived pulsatility index (PI) reported a 95% CI for prediction of 4.2 mmHg17. Such 
an optimistic accuracy was not confirmed by other authors: with paediatric patients the 
absolute value of TCD-derived pulsatility index (PI) was found to be an unreliable non-
invasive estimator for ICP in TBI18. Correlation with ICP in this case was 0.36 (p=0.04), much 
weaker than the correlation found by Bellner et al. in adults (R=0.938, p<0.0001)17.   
Other TCD approaches for non-invasive ICP monitoring were originally intended for 
estimating the non-invasive cerebral perfusion pressure (nCPP). However, non-invasive ICP 
can be calculated based on the assumption that nICP = ABP - nCPP30,31.   
Because of the variability in the reported degree of agreement between TCD-based nICP 
methods and measured ICP, this study aimed to systematically compare 4 TCD-based nICP 
methods with measured ICP in a single prospective cohort of TBI patients. 
 
 
 
  
 
 
 
 
 
 
Materials and methods 
 
Patient population 
 
This study included prospectively collected data from 40 traumatic brain injury patients (32 
males (80%), 8 females (20%), population mean age 35±15 years), hospitalized in the 
Neurocritical Care Unit of Addenbrooke’s Hospital between 2013 and 2015. Patients were 
sedated, ventilated, and managed in the Neurocritical Care Unit with a therapeutic protocol 
aiming for an ICP <25 mmHg and CPP around 60–70 mmHg. The median pre-intubation 
Glasgow Coma Scale (GCS) score of the patients was 6 (range 3–14). The data included daily 
recordings of ABP, ICP, and TCD, in a total of 66 recordings. Informed consent was obtained 
from all patients (or their next of kin) for the use of collected data for research purposes. 
The study was approved by the research ethics committee (29 REC 97/291). 
 
Data collection and calculations 
 
For ABP recordings, a pressure monitoring kit (Baxter Healthcare Health Care Corp. Cardio 
Vascular Group, Irvine, CA, USA) at the radial artery was used, zeroed at the level of the 
heart. ICP monitoring was performed via an intraparenchymal probe (Codman ICP 
MicroSensor, Codman & Shurtleff, Raynham, MA, USA). Cerebral blood FV was obtained 
from the MCA, bilaterally when possible, with a 2-MHz probe and monitored with the 
Doppler Box (DWL Compumedics Ltd, Germany). The TCD recordings were performed for 
periods ranging from 10 minutes up to 1 hour, starting from the day of initiation of invasive 
ICP monitoring. An analog–digital converter was used to digitize the raw data signals at a 
sampling frequency of 50 Hz, which were then recorded using ICM+ software (Cambridge 
Enterprise, http://www.neurosurg.cam.ac.uk/icmplus/). All calculations, including mean 
values of ABP, ICP and FV were performed over a moving average window of 10 seconds. 
For FV, the right MCA was chosen because the intraparenchymal ICP probe was inserted on 
the right side, but in recordings which right FV was of poor quality and left side was better, 
left side was taken instead. 
 
Non-Invasive ICP methods 
 
The four methods used for nICP estimation in this study were:  
 
1) Schmidt et al. ”black-box” (BB) model20 (nICP_BB): in this model, the intracranial 
compartment was considered a black-box system. This mathematical model is based 
on results from systems analysis, which provides a method to describe systems, in 
particular physiological systems, with input and output signals. The outgoing signals 
are considered the system’s responses to its stimulation by incoming  signals. In this 
case, the intracranial compartment was indirectly described by a transfer function 
approach32,33 which connected the assumed input signal ABP with the output signal 
ICP (nICP). The transformation rules between ABP and ICP were controlled and 
continuously adjusted by selected hemodynamic parameters (TCD-characteristics), 
characterising patterns of FV as well as the ABP-FV relationship. The output data 
provides full waveform of nICP (in mmHg). Constant relationship between FV-ABP 
and ABP-nICP transformations was derived from analysis of database including 140 
TBI patients. Non-invasive ICP estimation using this method was performed using a 
plugin developed for ICM+ software. An illustrative representation of this model is 
presented in Figure 1. 
 
2) Czosnyka et al.30 (nICP_FVd): Transcranial Doppler ultrasonography offers non-
quantitative measurements of cerebral blood flow (CBF). Global changes in CBF can 
be monitored continuously and non-invasively using blood flow velocity34. Over this 
concept, some studies have demonstrated that specific patterns of TCD waveform 
reflect inadequate cerebral perfusion caused by a decrease in CPP30,35. In such cases, 
there is a drop in diastolic flow velocity, whereas the systolic component remains 
relatively unchanged (as illustrated in Figure 2). These characteristics observed in the 
CBF velocity waveform pattern can be used as indicators of perfusion derangements 
and have been applied as variables for nCPP estimation. For this method, based on 
waveform analysis of blood flow velocity measured in the middle cerebral artery 
(MCA), the diastolic flow velocity was used for the estimation of nCPP. nICP, on the 
other hand, was calculated as the difference between ABP and nCPP (nICP = ABP - 
nCPP). The equation for nCPP estimation was: 
 
           
   
   
           (Equation 1) 
 
FVd and FVm (cm/s) represent diastolic and mean flow velocity, respectively. 
 
 
3) Varsos et al.31 (nICP_CrCP): similarly, this method calculates nICP based on nCPP, in 
this case specifically using the concept of Critical Closing Pressure (CrCP). According 
to Burton’s model, CrCP is equal to the sum of ICP and vascular wall tension 
(WT)36,37: CrCP = ICP + WT. By definition, critical closing pressure denotes a threshold 
of ABP, below which the brain microvascular blood pressure is inadequate to 
prevent the collapse and cessation of blood flow36. Given the association of CrCP 
with the vasomotor tone of small blood vessels  (i.e., wall tension), this concept may 
be able to provide information regarding the state of cerebral haemodynamics in 
several neurological conditions36,38–41, and for this method was applied as a variable 
for nCPP estimation. Figure 3 illustrates the concept of critical closing pressure, 
showing its interaction with ICP and WT in a situation of intracranial hypertension. 
The equation for nCPP estimation is: 
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CVR (mmHg/(cm/sec) represents cerebral vascular resistance, Ca (cm/mmHg) denotes 
compliance of the cerebral arterial bed and HR expresses heart rate (beats/sec), with ABP 
and FV as the required measurements. Finally, nICP can be obtained as the difference 
between ABP and nCPP (nICP = ABP - nCPP). Constant coefficients (0.734, 0.266, 7.026 
mmHg) are derived from analysis of database of 232 retrospective cases31. 
 
 
4) nICP_PI: Pulsatility index describes quantitatively and qualitatively changes in the 
morphology of the TCD waveform resulting from CVR changes. It is a relationship 
between the difference of Fvs (systolic flow velocity) and FVd divided by FVm (Figure 
4 and Equation 4). PI-based methods rely on the observation that during rise in ICP, 
pulsatility index increases. However, there are several situations in which PI may 
increase independently of an increase in ICP. This may occur, for example, during 
lowering in CPP (which may involve either a rise in ICP or a decrease in ABP), and 
also during hypocapnia or increase in pulsatility of ABP waveform. nICP estimation 
based on TCD-derived PI was based on the linear regression among known values of 
ICP and PI from a population cohort of 292 TBI patients. The regression equation was 
based on data analysed by Budohoski et al.42 and given by:  
 
                          (Equation 3) 
 
 
   
       
   
        (Equation 4) 
 
 
Statistical analysis 
 
Statistical analysis of the data was conducted with OriginPro statistical software (version 8, 
OriginLab Corporation). The analysis included correlations between non-invasive ICP 
estimators and measured ICP in terms of mean values, with R representing the Pearson 
correlation coefficient, with the level of significance set at 0.05. Results were presented as 
mean±SD. The Bland-Altman method was used to determine the agreement between 
invasive ICP and the different nICP methods, with their respective 95% CI for prediction and 
bias. The confidence interval represents the method’s estimation performance and 
contemplates the range of values around the bias (absolute difference between mean 
values of nICP and ICP) in which data can be found with a significance level of 0.05. The area 
under the curve (AUC) of the receiver operating characteristic curve (ROC) was applied to 
determine the ability of the non-invasive methods to predict raised ICP (using a threshold of 
17 mmHg). This threshold was chosen due to its proximity to values which would commonly 
prompt treatment in the clinical setting (normally above 20-25 mmHg1). The predicting 
ability is considered reasonable when the AUC is higher than 0.7 and strong when the AUC 
exceeds 0.843. For recordings which mean ICP changes were greater than 7 mmHg, averaged 
correlation between ICP and nICP methods was calculated in time domain, as well as 
correlation between ∆ICP and ∆nICP. In this case, “∆” is the difference between maximum 
and minimum mean value in each recording during ICP changes.  
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
Results 
 
Table 1 presents basic demographic characterization of the prospective cohort.   
Out of the 66 recordings, 8 presented a considerable spontaneous variation of ICP (∆ICP) ≥7 
mmHg in time domain. An example of nICP recording with the four investigated methods is 
presented in Figure 5. Averaged correlation coefficients between real trend of ICP and nICP 
were summarized in Table 2. In the same table, correlations between ∆ICP and ∆nICP were 
compared. 
Statistical comparisons among non-invasive methods adopted in this work are presented in 
Table 3. It takes into consideration all 66 TCD recordings as separate events and includes  
Pearson correlations, Bland-Altman analysis (95% CI for predictions and bias) and area 
under the curves obtained from ROC analysis for an ICP threshold of 17 mmHg. As observed 
in Table 1, the cohort presented low range of mean ICP values, which made necessary the 
use of a threshold close to, but bellow critical values for intracranial hypertension 
treatment, in order to obtain a consistent ROC analysis. 
nICP_BB, nICP_FVd and nICP_CrCP demonstrated moderate but significant correlations 
(p<0.05) with measured ICP; while nICP_PI had poor correlation with measured ICP (p>0.05) 
(figure 6). In regards to Bland-Altman analysis, nICP_BB and nICP_PI showed biases close to 
zero, and along with nICP_CrCP, presented similar 95% CI (around 10 mmHg). FVd-based 
method showed greater bias and 95% CI (figure 7). In Figure 7, each plot was complemented 
by the corresponding error histogram, on which the plot of a Gaussian (normal) distribution 
of the same bias and 95% CI is superimposed for visual comparison. The Gaussian 
distribution and 95% CI represent the interval in which data are not randomly distributed.  
The best AUC value was presented by nICP_FVd (AUC=0.70). In addition, table 3 also 
presents results from the arithmetic average of only the best non-invasive ICP estimators 
(nICP_Av), i.e., nICP_BB, nICP_FVd and nICP_CrCP, which generally showed slightly improved 
statistics, with AUC=0.73 (figure 8). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
Discussion 
 
In this comparison of TCD-based nICP estimators, we found a significant, albeit not very 
strong relationship between nICP and measured ICP. Of the 4 studied estimators, nICP_BB 
appeared to have the strongest relationship with measured ICP understood ‘as a number’- 
i.e. averaged value of nICP assessed during single TCD session. For replicating trace of 
measured ICP in time in individual patient, nICP_PI proved to provide best accuracy. 
Potential explanations and comparison with previous studies are discussed below.  
Monitoring of  ICP dynamics can be done most efficiently with nICP_PI method, which 
showed the strongest mean correlation coefficient across 8 patients (R=0.61), followed by 
nICP_BB (R=0.48). However none of the methods presented satisfactory correlation of 
∆nICP with ∆ICP, nICP_BB was the best considering variations of ICP ≥7 mmHg (R=0.68, 
p=0.06). Considering “∆” as the difference between maximum and minimum values, it 
represents the ability of the nICP methods to detect differences in the magnitude of a 
change in measured ICP recorded in time. 
Certain events, as critically reduced CPP in the setting of intracranial hypertension in TBI, as 
well as episodic rises in ICP caused by hyperaemia, can be identified by marked reductions 
in TCD flow velocity44. As ICP increases and CPP correspondingly decreases, a characteristic 
highly pulsatile flow velocity pattern is observed. Continuing increases in ICP result first in a 
reduction and then loss of diastolic flow, progressing to an isolated systolic spike of flow in 
the TCD waveform, and eventually to an oscillating flow pattern which signifies the onset of 
intracranial circulatory arrest45,46. Even though accuracy for mean ICP changes presented in 
this work did not demonstrate a strong correlation with measured ICP, cerebral circulation 
dynamics can be observed with the TCD-based methods as nICP changes in time domain, 
and tracked in real-time in the clinical setting. This form of monitoring is one of the 
advantages of Transcranial Doppler Ultrasonography and may become particularly useful as 
a primary assessment tool in centres where ICP measurements are not routinely applied, or 
in patients in whom ICP monitoring is unavailable or may not be clearly indicated (mild 
closed head injury, for example).   
Treating each monitoring session as an independent event and calculating averaged nICP, 
the comparison of four methods indicates nICP_BB to be the best statistically-wise, as it 
presented the most consistent indicators for prediction of ICP. In regards to bias, for 
instance, a non-significant difference between non-invasive and invasive methods is 
desirable, which means that both methods are not different in rendering mean ICP values. 
For nICP_BB, bias was not significantly different from zero and 95% CI for prediction was 
even smaller as previously reported by Schmidt et al. (12.8 mmHg)15 or Heldt et al. (15 
mmHg), in their model also based on TCD and ABP27. In addition, AUCs for nICP_BB were 
close to reasonable values (0.7) and asymptotic probabilities for ROC analysis were also 
significant, denoting the method’s ability to detect differences between high and normal ICP 
values. 
In contrast, nICP_FVd and nICP_CrCP both presented biases significantly different from zero. 
However, for nICP_FVd, moderate correlation coefficients and reasonable AUC were 
observed. nICP_CrCP, conversely, did not present significant asymptotic probabilities for 
AUC according to ROC analysis. Considering 95% CI, nICP_FVd had the greatest prediction 
error and nICP_CrCP the smallest.  
nICP_PI, despite the best ability to detect changes in ICP across time, did not show any 
consistent statistical parameter for estimating ICP as to correlation with mean values, CI and 
AUC, and thus can be considered the weakest estimator. This assumption contradicts results 
published by Bellner et al. in their previous study for the assessment of the relationship 
between PI and ICP, that PI would strongly correlate with ICP17. On the other hand, it is in 
agreement with results from Figaji et al., whose work shows that PI is not a reliable non-
invasive estimator of ICP in children with severe TBI18.  
Averaging estimation methods is a useful computational technique, capable of 
approximating the different features of each estimator considered. In our case, in an 
attempt to find a more reliable method using this approach, we averaged those which 
presented the best estimation for ICP ‘as a number’, i.e., nICP_BB, nICP_FVd and nICP_CrCP. 
The inclusion of nICP_PI in the average did not yield any improvement in estimation. Named 
nICP_Av, it proved to approximate the most consistent characteristics of its three 
components, in comparison to single methods. In comparison to nICP_BB, for instance, 
which was the best estimator out of the three considered, nICP_Av only presented inferior 
values as to bias, which was significantly different from zero. Thus, this new estimator might 
represent a more reliable way to predict ICP non-invasively, possibly because it takes 
advantage of a broader set of inputs (ABP, FV, FVd and CrCP).   
Regarding inputs, the different nICP accuracies observed may be explained by what each 
method is fundamentally based on. nICP_BB, for instance, reflects ABP waveform being 
constantly modified by TCD characteristics, and then is mostly susceptible to changes of 
vascular components (such as cerebrovascular resistance, arterial compliance) and 
consequently cerebral blood flow. nICP_FVd, which is derived from a non-invasive 
estimation of CPP (Equation 1), is mostly modulated by the factor FVd/FVm, which is evident 
during hyperventilation, when FVd/FVm decreases due to vasodilation30. It also replicates 
changes in ICP provoked by rapid changes in ABP, as mean ABP is a multiplier in the formula.  
nICP_CrCP, according to Equation 2, is also modulated by changes in CVR and Ca. For 
nICP_PI, it is known that decreasing CPP produces (like during plateau waves of ICP) specific 
changes in FV with stable systolic and falling diastolic values 45,47. These changes may be 
observed in the pulsatility index, which has been reported to be inversely proportional to 
CPP45,47. Although all methods essentially reflect changes in cerebrovascular parameters,  
which lead to variations of cerebral blood flow velocity acquired via TCD ultrasonography,  
each one is modulated by different factors.  
Provided that the confidence intervals for prediction of ICP for all nICP methods were 
determined, a question that can be raised out of this is regarding the degree of accuracy 
expected or required for a non-invasive monitor to be considered a clinically useful tool in 
estimating ICP. According to the Association for Advancement of Medical Instrumentation 
(AAMI), all sorts of ICP monitoring devices should have continuous output in the 0-100 
mmHg range with an accuracy of ±2 mmHg in the 0-20 mmHg range, and maximum 
prediction error of 10% for ICP above 20 mmHg, the specifications supported by the Brain 
Trauma Foundation guidelines14,48. In the case of this study, the estimation performance 
represented by the 95% CI for prediction of ICP ranged around 10 mmHg, with all methods 
above these specified limits.  
Another aspect that should be taken into consideration when assessing new non-invasive 
modalities is to examine the accuracy of current invasive methods and their mutual 
agreement. In the clinical practice, ventricular and parenchymal pressure methods remain 
as the primary approaches to ICP monitoring. However, epidural probes are also often used. 
Simultaneous measurement of ICP by a parenchymal probe and ventriculostomy showed a 
bias of −1.2 and a 95% CI of 6.8 mmHg (SDE of 3.4 mmHg)49. In another study, simultaneous 
measurements of ICP using a parenchymal probe and an epidural probe presented a bias of 
4.3 mmHg, with 95% CI of 17 mmHg (SDE of 8.5 mmHg)50. 
Although it would be ideal that TCD-based nICP methods presented similar measures of 
accuracy to the invasive ones, it is important to highlight that these techniques are 
subjected to certain interferences (signal attenuation and movement artefacts, for instance) 
which certainly influence their degree of accuracy. Nevertheless, considering the 
performance characteristics reported for invasive methods, the nICP methods applied in this 
study, showing biases ranging from -0.5 to 7.34 mmHg and 95% CI from 9.19 to 14.68 mmHg 
(Table 3), in general performed better than the invasive epidural method still used in the 
clinical management of patients. 
As mentioned previously, TCD-based nICP methods, despite their intrinsic limitations to 
predict absolute mean ICP values, may have a potential clinical utility as a primary 
assessment tool in diagnosing intracranial hypertension in TBI and other conditions 
especially in the early stages of management, due to its ability to detect cerebrovascular 
derangements originated from ICP changes. 
In this context, out of the four methods compared, nICP_BB proved to be the best estimator 
for ICP in this cohort of TBI patients. Methods based on diastolic FV and CrCP showed 
intermediate accuracy. Pulsatility index method presented good correlation in time domain 
during variations of ICP. We suggested a new method based on averaging nICP_BB, 
nICP_FVd and nICP_CrCP, which overall demonstrated stronger statistical indicators for ICP 
prediction.  
 
 
Limitations  
 
During the process of data analysis, we found that poor quality of TCD recordings has 
profound effects on the accuracy of the methods assessed. Aspects such as depleted signal 
resolution and noise (example in figure 9) may act as limitations to the study and must be 
prevented for meaningful nICP estimation. Good quality of TCD and ABP recordings are 
essential requirements for ICP estimation using TCD-based methods, and then must be met 
accordingly in future investigations. TCD quality depends, among other parameters, on the 
experience of the operator for accurately insonating the targeted artery (MCA). Additionally, 
unlike ABP measurements, TCD monitoring was not continuous but instead it consisted of 
short recordings for every patient, therefore preventing a continuous nICP assessment. 
Shortcomings for continuous monitoring were mainly related to the routine of the 
neurointensive care environment, where treatment of patients requires changes of body 
position and transfers for imaging procedures, which hindered the possibility of continuous 
or longer TCD recordings with existing probe holders. 
The use of radial artery ABP zeroed at the level of the heart instead of actual blood pressure 
in the brain could also be considered a limitation to the study. This condition might non-
accurately approximate peripheral ABP to intracranial ABP, which can specifically change 
the accuracy of methods that rely on ABP waveform analysis, such as nICP_BB. Moreover, 
heart-level calibration leads to an overestimation of CPP51, yielding a difference that might 
affect the calculation of nCPP (i.e. for nICP_CrCP and nICP_FVd methods) that derives 
information from ABP measurements31.  
Changes in cerebrovascular resistance, such as that produced by variations in PaCO 2, may 
disturb CPP estimation (nCPP), and could also act as a limitation or confounding factor to 
the study. As observed by Czosnyka et al.30, although an increase in arterial CO2 tension 
(from mild hypocapnia to normocapnia) decreased the measured CPP (due to associated 
decrease in ABP), it resulted in a slight increase in nCPP (mainly because of an increase in 
the FVd/FVm factor due to vasodilation). In such conditions, for example, nICP_FVd method 
would render an underestimation of nICP. 
Low range of ICP values found in the patient’s cohort as observed in Table 1 may also consist 
of a limitation, as it prevented a more extensive analysis on how nICP methods behave in 
conditions of elevated intracranial pressure. This characteristic may be attributed to the 
therapeutic protocol patients were submitted. 
Finally, the fifth possible method based on TCD, as described by Heldt et al.19,27, was not 
compared, as a replication of very complex algorithm on a basis of description given in 
literature was not possible, mainly due to phase shift between ABP and FV time series  (MB – 
personal communication). 
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